In December 2022, Brian presented a talk entitled “New Approaches to Site-Specific Bioconjugation” at the University of Virginia in Charlottesville, Virginia.

​

In November 2022, Brian presented a talk entitled “Leveraging Bioorthogonal Chemistry for In Vivo Pretargeting” at the 2022 Symposium on Evolving Targeted Therapies for Cancer at Oak Ridge National Laboratory in Tennessee.

​

In October 2022, Brian accepted the Roger Tsien Award from the World Molecular Imaging Society and presented an award lecture entitled “Biorthogonal Chemistry for Better Radiopharmaceuticals” at the World Molecular Imaging Congress in Miami, Florida.

​

In October 2022, Outi presented a poster entitled “PET imaging of Gal-3BP expression in PDX models” at the World Molecular Imaging Congress in Miami, Florida.

​

In September 2022, Cindy gave a talk  entitled “Harnessing Mushroom Tyrosinase and the Strain-Promoted Oxidation-Controlled 1,2-Quinone Cycloaddition for the Synthesis of Site-Specifically Modified 89Zr-Radioimmunoconjugates” at TERACHEM 2022: The Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine in Bressanone, Italy.

​

In September 2022, Doug gave a talk  entitled “A 177Lu-Labeled Anti-HER2 Dual Variable Domain Antibody” at TERACHEM 2022: The Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine in Bressanone, Italy.

 

In September 2022, Sam S. gave a talk  entitled “Visualizing SCLC in Advanced Murine Models via ImmunoPET with a 89Zr-Labeled Radioimmunoconjugate” at TERACHEM 2022: The Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine in Bressanone, Italy.

​

In September 2022, Samantha D. gave a talk  entitled “Photoaffinity Labeling for the Site-Specific Bioconjugation of 89Zr-Labeled Radioimmunoconjugates” at TERACHEM 2022: The Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine in Bressanone, Italy.

​

In September 2022, Outi presented a poster entitled “Harnessing 89Zr-PET to Study the Pulmonary Clearance of Microplastics in Mice” at TERACHEM 2022: The Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine in Bressanone, Italy.

​

In August 2022, Outi gave a talk entitled “A Chemoenzymatic Approach to the Synthesis of Site-Specifically Modified Radioimmunoconjugates” at the Annual Meeting of the American Chemical Society in Chicago, Illinois.

​

In June 2022, Outi gave a talk entitled “Real-Time Tracking of Micro- and Nanoplastic Pollutants in Mice with PET imaging” at Chemical Sciences in Biological Challenges 2022 in Kuopio, Finland.

​

In March 2022, Outi gave a talk entitled "Tracking Micro- and Nanoplastics Non-Invasively in Mice with PET Imaging" at the 2022 Annual Meeting of the Society of Toxicology in San Diego, California

​

In February 2022, Brian will gave a talk entitled "The Interplay Between Radioimmunoconjugates and the Immune System" at North Carolina State University in Raleigh, North Carolina.

​

In December 2021, Brian gave a virtual talk entitled "Harnessing Bioorthogonal Chemistry for Nuclear Imaging and Endoradiotherapy" at Karmanos Cancer Center at Wayne State University in Detroit, Michigan.

 

In December 2021, Brian gave a virtual talk entitled "Harnessing Bioorthogonal Chemistry for Nuclear Imaging and Endoradiotherapy" at the University of Newcastle in Newcastle, England.

 

In February 2021, Outi gave a virtual talk entitled "Theranostic Approaches in IEDDA-Based Pretargeted Radioimmunotherapy" at the Turku PET Centre in Turku, Finland.

 

In August 2021, Outi gave a virtual talk entitled "Theranostics in IEDDA-Based In Vivo Pretargeting" for the World Molecular Imaging Society's Women in Molecular Imaging Network Webinar Series.

 

In October 2021, Cindy gave a talk entitled "The Synthesis and In Vivo Evaluation of Variants of 89Zr-DFO-Pertuzumab Synthesized Using Random and Site-Specific Lysine Modification Strategies" at the 2021 Virtual World Molecular Imaging Congress.

 

In October 2021, Samantha D. gave a talk entitled "The Synthesis and In Vivo Evaluation of a Cadherin-17-targeted Radioimmunoconjugate for the PET Imaging of Pancreatic Adenocarcinoma" at the 2021 Virtual World Molecular Imaging Congress.

 

In October 2021, Outi gave a talk entitled "Tracking Micro- and Nanoplastics in Mice with PET Imaging" at the 2021 Virtual World Molecular Imaging Congress.

​

In October 2021, Brian gave a virtual talk entitled "Antibodies as Radiopharmaceutical Vectors: Do the Benefits Outweigh the Costs?” to the 2021 Annual Meeting of the European Association of Nuclear Medicine in Hamburg, Germany. 

 

In August 2021, Brian gave a virtual talk entitled "Theranostic Pretargeting with a 64/67Cu Isotopic Pair" at the 2021 Department of Energy Cu-67 User Group Meeting.

 

In July 2021, Brian gave a virtual talk entitled "Leveraging Click Chemistry for Nuclear Imaging and Therapy" to the 2021 Nuclear Chemistry Summer School at Brookhaven National Laboratory. 

 

In June 2021, Brian gave a talk entitled "Harnessing Click Chemistry for Pretargeted PET Imaging and Radioimmunotherapy" at Weill Cornell Medical College in New York City, New York.

 

In May 2021, Brian participated in a debate session entitled "Robin Hood and the Merry Pretargeteers" at the 2021 Virtual Meeting of the Society of Radiopharmaceutical Sciences

 

In August 2020, Brian gave a talk entitled "In Vivo Pretargeting: Radiosynthesis at the Tumor Surface" at the Department of Energy's Virtual Summer School in Nuclear and Radiochemistry.

 

In August 2020, Brian gave a talk entitled "Harnessing the Heavy Chain Glycans for the Creation of SIte-Specifically Modified Radioimmunoconjugates" at the Virtual Annual Meeting of the Australia and New Zealand Society of Nuclear Medicine.

 

In July 2020, Brian gave a talk entitled "In Vivo Pretargeting: Radiosynthesis at the Tumor Surface" at the Virtual Annual Meeting of the Australia and New Zealand Society of Nuclear Medicine.

 

In June 2020, Outi gave a talk entitled "Pretargeted Theranostic Radioimmunotherapy with a 64Cu/67Cu Isotopologue Pair" at the Virtual Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.

 

In June 2020, Brian presented the Radiochemistry and Radiopharmacy Highlights Lecture at the Virtual Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.

 

In September 2019, Outi gave a talk entitled "Harnessing 67Cu for Click-Mediated Pretargeted Radioimmunotherapy and SPET Imaging" at the World Molecular Imaging Congress in Montreal, Canada.

 

In July 2019, Brian gave a talk entitled "ImmunoPET: Leveraging Antibodies for Diagnostic and Theranostic Nuclear Imaging" at the annual meeting of the American Association of Physicists in Medicine in San Antonio, Texas.

​

In June 2019, Brian gave a talk entitled "In Vivo Pretargeted Radiotherapy with Metallic Radionuclides" at Northeast Region Meeting of the American Chemical Society in Saratoga Springs, New York

 

In June 2019, Brian gave a talk entitled "In Vivo Pretargeted Radiotherapy with Metallic Radionuclides" at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging in San Diego, California.

​

In May 2019, Outi gave a talk entitled "Dual Radionuclide Theranostic Pretargeting" at the International Symposium on Radiopharmaceutical Sciences in Beijing, China.

​

In May 2019, Brian gave a talk entitled “Getting Your Papers Published (and Noticed!) When You Start Your Own Lab” at the International Symposium on Radiopharmaceutical Sciences in Beijing, China.

​

In April 2019, Brian gave a talk entitled "The Emergence of 89Zr ImmunoPET: Harnessing Antibodies for Nuclear Imaging” at Iona College in Scarsdale, New York.

​

In December 2018, Brian gave a talk entitled "Pretargeted Radioimmunotherapy Based on Bioorthogonal Click Chemistry" at the University of Copenhagen in Copenhagen, Denmark.

​

In December 2018, Outi presented a talk on her graduate work at the Imaging Sciences Seminar at Memorial Sloan Kettering Cancer Center in New York, New York

​

In November 2018, Rosemery defended her thesis -- "Pretargeted Radioimmunotherapy Utilizing the Inverse Electron Demand Diels-Alder Reaction" -- at Hunter College in New York City, New York.

​

In September 2018, Brian gave a talk entitled "In Vivo Pretargeting: Radiosynthesis at the Tumor Surface" at Stony Brook University in Stony Brook, New York. 

​

In September 2018, Stephen gave a talk entitled "Auger-Electron Emitting PARP1/2 Targeted Radio-Theranostic for Glioblastoma" at the World Molecular Imaging Congress in Seattle, Washington.

 

In September 2018, Rosemery presented a poster entitled "The Optimization of Click-Mediated Pretargeted Radioimmunotherapy" at the 3rd International Edition of the Symposium on Technetium and other Radiometals in Chemistry and Medicine (TERACHEM) in Bressanone, Italy.

​

In September 2018, Kimberly presented a poster entitled "The Development of a MUC1-Targeted PET Probe for Ovarian Cancer" at the 3rd International Edition of the Symposium on Technetium and other Radiometals in Chemistry and Medicine (TERACHEM) in Bressanone, Italy.

 

In September 2018, Brendon gave a talk entitled "Bifunctional Dendrimer Scaffold Leads to Increased Tumor Uptake" at the 3rd International Edition of the Symposium on Technetium and other Radiometals in Chemistry and Medicine (TERACHEM) in Bressanone, Italy.

​

In June 2018, Brian presented the Radiochemistry and Radiopharmacy Highlights Lecture at the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging in Philadelphia, Pennsylvania.

​

In June 2018, Brendon defended his thesis -- "The Development of Novel Platforms for the Imaging of Cancer by Positron Emission Tomography" -- at Hunter College in New York City, NY.

​

In April 2018, Brian gave a talk titled "In Vivo Pretargeting: Radiosynthesis at the Tumor Surface" at the Vrije Universiteit Amsterdam in Amsterdam, the Netherlands.

​

In April 2018, Brian gave a talk titled "In Vivo Pretargeting: Radiosynthesis at the Tumor Surface" at the Workshop on Immuno-Imaging and Molecular Therapy at the Vrije Universiteit Brussel in Brussels, Belgium.

​

In March 2018, Brian gave a talk titled "In Vivo Pretargeting: Radiosynthesis at the Tumor Surface" at the UCLA Crump Institute for Molecular Imaging in Los Angeles, California.

​

In March 2018, Delphine gave a talk titled "The Influence of Chelator Conjugation Method on ImmunoPET Imaging" at the National Meeting of the American Chemical Society in New Orleans, Louisiana.

​

In March 2018, Pierre gave a talk titled "A 68Ga-Labeled Tracer for the Pretargeted PET Imaging of Colorectal Cancer" at the National Meeting of the American Chemical Society in New Orleans, Louisiana.

​

In December 2017, Brian gave a talk titled "A Primer in 89Zr-ImmunoPET" at the 2017 Annual Meeting of the Radiology Society of North America in Chicago, Illinois.

​

In September 2017, Brian organized an educational session sponsored by the Early State Professionals in the Molecular Imaging Sciences (ESPMIS) interest group at the World Molecular Imaging Congress in Philadelphia, Pennsylvania.

 

In June 2017, Brian gave a talk entitled “In Vivo Pretargeting: Radiosynthesis at the Tumor Surface” at the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging in Denver, Colorado.

​

In May 2017, Brendon presented a poster called “Pretargeted PET Imaging of Bone Using a Trans-cyclooctene-Labeled Bisphosphonate” at the 22nd International Symposium on Radiopharmaceutical Sciences in Dresden, Germany.

 

In May 2017, Rosemery gave a talk titled “Pretargeted Radioimmunotherapy (PRIT) of Colorectal Carcinoma based on Bioorthogonal Diels-Alder Click Chemistry” at the 22nd International Symposium on Radiopharmaceutical Sciences in Dresden, Germany.

 

In May 2017, Pierre gave a talk titled “Novel Reagents for the Site-Specific Modification of Proteins and Peptides with Radiometal Chelators” at the 22nd International Symposium on Radiopharmaceutical Sciences in Dresden, Germany.

 

In May 2017, Delphine presented a poster called “The Impact of FcRI Receptor Binding on ImmunoPET Imaging” at the 22nd International Symposium on Radiopharmaceutical Sciences in Dresden, Germany.

 

In April 2017, Brian gave a talk titled “In Vivo Pretargeting: Radiosynthesis at the Tumor Surface” to the Division of Chemistry and Chemical Biology at the California Institute of Technology in Pasadena, California.

 

In April 2017, Brian gave a talk titled “In Vivo Pretargeting: Radiosynthesis at the Tumor Surface” to the Department of Molecular Medicine at City of Hope Hospital in Duarte, California.

 

In April 2017, Brian gave a talk titled “Bioorthogonal Chemistry for Better Radiopharmaceuticals” to the Department of Chemical Biology and Therapeutics at St. Jude Children’s Hospital in Memphis, Tennessee.

 

In April 2017, Brian gave a talk titled “In Vivo Pretargeting: Radiosynthesis at the Tumor Surface” to the Department of Diagnostic Imaging at St. Jude Children’s Hospital in Memphis, Tennessee.

​

In March 2017, Brian gave a talk titled “In Vivo Pretargeting: Radiosynthesis at the Tumor Surface” to the Department of Chemical Biology at the University of Missouri in Columbia, Missouri. 

​

In December 2016, Brian gave a talk entitled “A Primer in 89Zr-ImmunoPET” at the 2016 Annual Meeting of the Radiology Society of North America in Chicago, Illinois.

 

In October 2016, Pierre gave a lecture entitled “Bioorthogonal Chemistry: Impact on Molecular Imaging” at the Northeast Regional Meeting of the American Chemical Society in Binghamton, New York. 

 

In October 2016, Brian gave a talk entitled “Strategies for the Site-Specific Bioconjugation of Antibodies” at the 29th Annual Congress of the European Association of Nuclear Medicine in Barcelona, Spain.

 

In September 2016, Pierre presented a poster entitled “Site-Specifically Labeled Immunoconjugates PET Imaging and Antibody-Drug Conjugate Therapy” at the World Molecular Imaging Congress in New York, New York.

 

In September 2016, Brian gave a talk entitled “The Anatomy of a Radioimmunoconjugate” at the World Molecular Imaging Congress in New York, New York.

 

In June 2016, Brendon gave a talk titled “Pretargeted PET Imaging Using a Site-Specifically Modified Immunoconjugate” at the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging in San Diego, California.

 

In June 2016, Rosemery presented a poster titled “The Synthesis, Radiolabeling, and Characterization of 177Lu-Labeled Tetrazine Radioligands for Pretargeted Radioimmunotherapy” at the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging in San Diego, California.

 

In June 2016, Pierre gave a talked entitled “A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer” at the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging in San Diego, California.

 

In June 2016, Sai gave a talked entitled “A DLL3-Targeted Theranostic for Small Cell Lung Cancer: Imaging a Low Density Target with a Site-Specifically Modified Radioimmunoconjugate.” at the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging in San Diego, California.

 

In April 2016, Sai presented a talk titled “Tracing the Silent Killer – Molecular Imaging of Ovarian Cancer” to the Department of Chemistry at Hunter College of the City University of New York. 

 

In March 2016, Brian presented a talk titled “PET Imaging with 89Zr” to the Department of Chemistry of the University of the West Indies in Kingston, Jamaica. 

 

In March 2016, Brian gave a talk entitled “Harnessing Bioorthogonal Chemistry for Pretargeted Imaging and Therapy” at the Annual Symposium of the Memorial Sloan Kettering Cancer Center Imaging and Radiation Sciences Program in New York, New York.